Pilot Study: Evaluation of the efficacy of homeopathic anti-tumor protocols in Ehrlich tumor

Cancer is the second leading cause of death worldwide, with breast cancer one tumors highest incidence in Brazil, an estimated 57,120 new cases 2014. Several forms treatment and control symptoms has been studied, among them homeopathy. In Banerji clinic India, doctors have used a protocol consisting 4 homeopathic medicines relevant results that motivated this study. our research Ehrlich tumor was used, transplantable cell, whose features are similar carcinoma, as discovered 1905 by Paul Ehrlich. Objective: To analyze clinical immunomodulatory mice treated medications found Protocol thymulin 5CH. Methodology: The project approved under 158/13 Paulista University Ethics Committee. BALB / c between 6 9 weeks old were used. Each mouse inoculated 1x10 7 cells into peritoneum cavity, to obtain ascitic form tumor. Mice divided 5 groups (N=6 animals per group), being following treatments: sterile water, Conium maculatum 200CH, Thuja occidentalis Phytolacca decandra Carcinosinum every day 0.1mL/10g body weight. weighed consumption water feed measured daily. Clinical signals temperature also registered survival each group analyzed. Results: All presented reduction before death. peak majority D18, while had its D29. observed apathy, prostration, cyanosis, priapism, tachydyspnea, genital edema secretion, decreased general activity, hair bristling trembling. loose stools unique symptom, seen 20% mice; showed trembling sole affected mice. higher symptoms, involving up 80% mice, lower affecting no more than 40% weight (reduction ascites) longer survival, when compared other groups. Conclusion: pilot study directed us stage research, which histopathological immunohistochemical observation will be assessed, chosen next step.